Amplitude Therapeutics
PrivateLast Round
Grant
Nov 1, 2024
Total Funding Raised
$3.77M
Company Overview
Amplitude Therapeutics is a biotechnology company that develops ribonucleic acid medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amplitude Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Amplitude Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2024 | ||||
| Grant | Aug 20, 2024 | ||||
| Grant | Mar 7, 2024 | ||||
| Seed | Mar 7, 2024 |
Amplitude Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newpath Partners | Seed |
| CEPI | Grant |
| ARCH Venture Partners | Seed |
| Administration for Strategic Preparedness and Response | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Alta Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2024
Secured $2.04M in grant funding.
- Aug 20, 2024
$733K grant round completed.
Amplitude Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amplitude Therapeutics's valuation, stock price, and market status.
